Post by
Resilience19 on Feb 15, 2021 10:42am
25,000 tests/week in Q2
This is only speculation at this time but given the tests/week having tripled from Q4 to Q1 (4,000/wk to 12,000/wk), I wouldn't be surprises, given the current context (variants threat, availability of non-intrusive spit test etc), to see test double again in Q2, to 25,000 or so. Furthermore, as DM appears to be building capacity, as demand increases, I wouldn't be surprised to see this figure, yet again, double to 50,000ish/wk during Q3. Afterwards, as nationwide immunization-driven herd immunity builds up, it may be that these figures will decrease, but that is highly dependent on whether additional new variants don't wreck havoc. In short, we may end up being in a linger term testing pattern, although margins would likely decrease as competition and tests availabilities increase. Regardless 2021 is bound to be a very interesting COVID-related income generating year at that current 12,000/wk tests is nimble compared to what's to come. My two cents.
Comment by
Resilience19 on Feb 15, 2021 9:32pm
Yes I agree, 50,000/wk is a very aggressive figure but this is also a VERY rough guestimate only and bearing in mind all potential sources of testing (national and international). This said, I'm quite confident such a target would be achievable in the current context.